About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Molecular and Clinical Oncology
›
top-articles
Molecular and Clinical Oncology
1.0
(top 50%)
impact factor
2.6K
(top 10%)
papers
21.6K
(top 10%)
citations
43
(top 20%)
h
-index
1.0
(top 50%)
impact factor
2.7K
all documents
23.3K
doc citations
65
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Passive targeting of nanoparticles to cancer: A comprehensive review of the literature
Molecular and Clinical Oncology
2014
282
2
Specific organ metastases and survival in metastatic non-small-cell lung cancer
Molecular and Clinical Oncology
2015
218
3
Tumor markers for hepatocellular carcinoma
Molecular and Clinical Oncology
2013
204
4
Glioma and glioblastoma - how much do we (not) know?
Molecular and Clinical Oncology
2013
154
5
The role of peroxiredoxins in cancer
Molecular and Clinical Oncology
2017
145
6
Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (Review)
Molecular and Clinical Oncology
2017
114
7
Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)
Molecular and Clinical Oncology
2019
101
8
Epigenetic control of epithelial-mesenchymal-transition in human cancer
Molecular and Clinical Oncology
2013
100
9
FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis
Molecular and Clinical Oncology
2013
99
10
The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer
Molecular and Clinical Oncology
2014
96
11
Oral mucositis in cancer treatment: Natural history, prevention and treatment
Molecular and Clinical Oncology
2014
94
12
Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysis
Molecular and Clinical Oncology
2015
90
13
Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer
Molecular and Clinical Oncology
2015
83
14
Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients
Molecular and Clinical Oncology
2017
82
15
TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis
Molecular and Clinical Oncology
2016
76
16
Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention
Molecular and Clinical Oncology
2013
75
17
Clinical applications of nucleic acid aptamers in cancer
Molecular and Clinical Oncology
2014
74
18
Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring
Molecular and Clinical Oncology
2015
67
19
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis
Molecular and Clinical Oncology
2014
64
20
The proliferation marker thymidine kinase 1 in clinical use
Molecular and Clinical Oncology
2013
63
21
Features of ovarian cancer in Lynch syndrome (Review)
Molecular and Clinical Oncology
2014
63
22
Cardiotoxicity associated with targeted cancer therapies
Molecular and Clinical Oncology
2016
63
23
Multiple microRNAs as biomarkers for early breast cancer diagnosis
Molecular and Clinical Oncology
2020
63
24
Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: A systematic review and meta-analysis
Molecular and Clinical Oncology
2015
61
25
The biology of uterine sarcomas: A review and update
Molecular and Clinical Oncology
2013
59
26
The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer
Molecular and Clinical Oncology
2015
59
27
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
Molecular and Clinical Oncology
2016
59
28
Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad‑spectrum cancer gene therapy - A review of molecular mechanisms for oncologists
Molecular and Clinical Oncology
2018
57
29
Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis
Molecular and Clinical Oncology
2014
56
30
Expression of aquaporin-1 is a poor prognostic factor for stage II and III colon cancer
Molecular and Clinical Oncology
2013
55
31
Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer
Molecular and Clinical Oncology
2014
55
32
Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategies
Molecular and Clinical Oncology
2015
55
33
Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis
Molecular and Clinical Oncology
2014
53
34
Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance
Molecular and Clinical Oncology
2013
52
35
Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma
Molecular and Clinical Oncology
2013
52
36
Potency of non-steroidal anti-inflammatory drugs in chemotherapy
Molecular and Clinical Oncology
2015
51
37
Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers
Molecular and Clinical Oncology
2013
49
38
A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stress
Molecular and Clinical Oncology
2014
49
39
The evolution of proton beam therapy: Current and future status (Review)
Molecular and Clinical Oncology
2018
49
40
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
Molecular and Clinical Oncology
2013
48
41
Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review)
Molecular and Clinical Oncology
2014
48
42
Clinical characteristics and prognostic analysis of Krukenberg tumor
Molecular and Clinical Oncology
2015
48
43
The optimum marker for the detection of lymphatic vessels
Molecular and Clinical Oncology
2017
48
44
Osteosarcoma with metastasis at initial diagnosis: Current outcomes and prognostic factors in the context of a comprehensive cancer center
Molecular and Clinical Oncology
2014
47
45
Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer
Molecular and Clinical Oncology
2014
47
46
Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study
Molecular and Clinical Oncology
2014
47
47
General insight into cancer: An overview of colorectal cancer (Review)
Molecular and Clinical Oncology
2021
47
48
Oxidative stress response induced by chemotherapy in leukemia treatment (Review)
Molecular and Clinical Oncology
2018
46
49
Profiling analysis of circulating microRNA expression in cervical cancer
Molecular and Clinical Oncology
2016
45
50
Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer
Molecular and Clinical Oncology
2013
44
site/software ©
exaly
; All materials licenced under
CC by-SA
.